HOSPIPLAN
ActiveSummary
HOSPIPLAN has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5.2m and a net result of -€205,799. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 95% of 5046 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability28▼-35
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €340,000 at 30 days acceptable
Liquidity ample (current ratio 15.72 against 7.92 in 2024; short-term debt: 1.5% and cash: 5.1% of total assets), and 1.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
98.5%
Return on assets
-3.9%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 12-12-2025, 50 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
50 d early
2024
31 d early
2023
47 d early
2022
33 d early
2021
24 d early
2020
2 d early
2019
9 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 28 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close28-09-2026 today31-01-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€205,799
2024 · €566,554
Working capital
€1.1m▲ 4.7%
2024 · €1.1m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€54,519▼ 13.4%€30,307▼ 44.4%€57,893▲ 91.0%€93,642▲ 61.8%€49,473▼ 47.2%
Net result-€39,212below the sector's middle half▲ 63.3%-€33,116below the sector's middle half▲ 15.5%€14,731within the sector's middle half€566,554within the sector's middle half▲ 3,746%-€205,799below the sector's middle half
Equity€4.9mabove the sector's middle half▼ 0.8%€4.8mabove the sector's middle half▼ 0.7%€4.8mwithin the sector's middle half▲ 0.3%€5.4mabove the sector's middle half▲ 11.7%€5.2mwithin the sector's middle half▼ 3.8%
Total assets€4.9mwithin the sector's middle half▼ 1.1%€4.9mwithin the sector's middle half▼ 0.3%€4.9mwithin the sector's middle half▲ 1.3%€5.6mwithin the sector's middle half▲ 12.7%€5.3mwithin the sector's middle half▼ 5.1%
Debt€30,249▼ 31.2%€49,981▲ 65.2%€96,588▲ 93.2%€157,761▲ 63.3%€77,720▼ 50.7%
Working capital€969,594within the sector's middle half▲ 5.0%€981,543within the sector's middle half▲ 1.2%€1.0mwithin the sector's middle half▲ 4.3%€1.1mwithin the sector's middle half▲ 6.7%€1.1mwithin the sector's middle half▲ 4.7%
Solvency99.4%above the sector's middle half▲ 0.3pp99.0%above the sector's middle half▼ 0.4pp98.0%above the sector's middle half▼ 0.9pp97.2%above the sector's middle half▼ 0.9pp98.5%above the sector's middle half▲ 1.4pp
Current ratio33.05above the sector's middle half▲ 11.0720.64above the sector's middle half▼ 12.4211.60above the sector's middle half▼ 9.047.92above the sector's middle half▼ 3.6715.72above the sector's middle half▲ 7.80
Return on assets (ROA)-0.8%below the sector's middle half▲ 1.4pp-0.7%below the sector's middle half▲ 0.1pp0.3%within the sector's middle half▲ 1.0pp10.2%above the sector's middle half▲ 9.9pp-3.9%below the sector's middle half▼ 14.1pp
above
within
below
the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 47% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.3m
Fixed assets
€4.1m ▼ 6.0%
Current assets
€1.2m ▼ 2.3%
Equity and liabilities €5.3m
Equity
€5.2m ▼ 3.8%
Debt
€77,720 ▼ 50.7%
Debt's share of the balance-sheet total falls from 2.8% to 1.5%. Equity and debt are lower.
Key figures and ratios
Quick ratio
14.49▲
2024 · 7.38
Debt to equity
0.01▼
2024 · 0.03
ROE
-4.0%▼
2024 · 10.5%
Debt ≤ 1 year
€77,720▼
2024 · €157,761
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | €868 | €1,074 | €1,060 | €1,020 | ▼ 3.8% |
| Gross operating margin9900 | €55,387 | €31,175 | €58,966 | €94,701 | €50,493 | ▼ 46.7% |
| Operating profit (loss)9901 | €54,519 | €30,307 | €57,893 | €93,642 | €49,473 | ▼ 47.2% |
| Financial income75/76B | - | - | - | €498,767 | €2,541 | ▼ 99.5% |
| Recurring financial income75 | - | - | - | €1,214 | €2,541 | ▲ 109% |
| Non-recurring financial income76B | - | - | - | €497,553 | - | - |
| Financial charges65/66B | - | €46,099 | €27,895 | €620 | €257,813 | ▲ 41,514% |
| Recurring financial charges65 | €805 | €1,034 | €689 | €620 | €424 | ▼ 31.6% |
| Non-recurring financial charges66B | - | €45,065 | €27,206 | - | €257,389 | - |
| Profit (loss) for the period before taxes9903 | -€31,974 | -€15,791 | €29,997 | €591,789 | -€205,799 | ▼ 135% |
| Income taxes67/77 | €7,238 | €17,325 | €15,266 | €25,235 | - | - |
| Profit (loss) for the period9904 | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | ▼ 136% |
| Profit (loss) for the period to be appropriated9905 | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | ▼ 136% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €4.9m | €4.9m | €4.9m | €5.6m | €5.3m | ▼ 5.1% |
| Fixed assets21/28 | €3.9m | €3.9m | €3.8m | €4.3m | €4.1m | ▼ 6.0% |
| Financial fixed assets28 | €3.9m | €3.9m | €3.8m | €4.3m | €4.1m | ▼ 6.0% |
| Current assets29/58 | €999,843 | €1.0m | €1.1m | €1.3m | €1.2m | ▼ 2.3% |
| Stocks and contracts in progress3 | €100,786 | €86,886 | €63,695 | €85,603 | €95,867 | ▲ 12.0% |
| Stocks30/36 | - | €86,886 | €63,695 | €85,603 | €95,867 | ▲ 12.0% |
| Amounts receivable within one year40/41 | €467,338 | €550,608 | €604,714 | €709,834 | €701,090 | ▼ 1.2% |
| Trade receivables40 | - | €352,293 | €255,450 | €330,102 | €279,811 | ▼ 15.2% |
| Other amounts receivable41 | - | €198,315 | €349,264 | €379,733 | €421,279 | ▲ 10.9% |
| Current investments50/53 | €150,005 | €150,005 | €150,005 | €150,926 | €152,710 | ▲ 1.2% |
| Cash at bank and in hand54/58 | €281,399 | €243,711 | €301,339 | €303,564 | €271,809 | ▼ 10.5% |
| Deferred charges and accrued income490/1 | - | €314 | €314 | €314 | €314 | = |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €4.9m | €4.9m | €4.9m | €5.6m | €5.3m | ▼ 5.1% |
| Equity10/15 | €4.9m | €4.8m | €4.8m | €5.4m | €5.2m | ▼ 3.8% |
| Contributions10/11 | - | €6.5m | €6.5m | €6.5m | €6.5m | = |
| Reserves13 | €250,693 | €250,693 | €250,693 | €250,693 | €250,693 | = |
| Non-distributable reserves130/1 | - | €250,693 | €250,693 | - | - | - |
| Reserves not available under the articles1311 | - | €250,693 | €250,693 | - | - | - |
| Distributable reserves133 | - | - | - | €250,693 | €250,693 | = |
| Profit (loss) carried forward14 | -€1.9m | -€1.9m | -€1.9m | -€1.4m | -€1.6m | ▼ 15.2% |
| Amounts payable17/49 | €30,249 | €49,981 | €96,588 | €157,761 | €77,720 | ▼ 50.7% |
| Amounts payable within one year42/48 | €30,249 | €49,981 | €96,588 | €157,761 | €77,720 | ▼ 50.7% |
| Trade debts44 | €20,716 | €32,298 | €75,004 | €125,841 | €70,536 | ▼ 43.9% |
| Suppliers440/4 | - | €32,298 | €75,004 | €125,841 | €70,536 | ▼ 43.9% |
| Taxes, remuneration and social security45 | - | €17,683 | €21,584 | €31,920 | €7,184 | ▼ 77.5% |
| Taxes450/3 | - | €17,683 | €21,584 | €31,920 | €7,184 | ▼ 77.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | ▼ 136% |
| Operating cash flow (approximation) | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | ▼ 136% |
| Investment in fixed assets (approximation) | - | €45,065 | €27,206 | -€497,553 | €257,389 | ▲ 152% |
| Change in cash | - | -€37,689 | €57,629 | €2,224 | -€31,755 | ▼ 1,528% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
12-12
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2024
31-12
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
30-06
Financial
Highest result since 2019net €566,554 ▲3,746%
Net result €566,554, the highest in the series.
30-06
Financial
Equity above €5mEq €5.4m ▲11.7%
2 profitable years in a row build equity to €5.4m.
2023
15-12
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
30-06
Financial
Back to profitnet €14,731
Net result €14,731 after 4 loss-making years.
2022
29-12
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
07-01
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
29-01
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
30-06
Financial
Liquidity triplescurrent ratio 21.99
Current ratio from 6.60 to 21.99; short-term debt falls from €157,709 to €43,985.
22-01
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
18-01
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
23-01
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
09-01
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 1997
Ground area
1,884 m²
Building footprint
1,188 m²
Volume, LiDAR
8,508 m³
Parcel 21015A0128/00Z000, Brussels · tallest building 11.9 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
HOSPIPLAN
since 19972.082.316.618
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21015A0128/00Z000 | Brussels | 1,884 m² | 1 · 1,187 m² | 11.9 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 30-06-2025 list no shareholders, and no other source names one.
Holdings 1
-
99.11%
According to the annual accounts to 30-06-2025 of HOSPIPLAN and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
KEYPHARM
BE 0883.397.311
Oostkamp · Eq €5,202,102
EDWARDS LIFESCIENCES BELGIUM
BE 0469.903.830
Vilvoorde · Eq €5,274,461
APEX
BE 0871.977.342
Braine-l'Alleud · Eq €5,137,280
COCHLEAR BENELUX
BE 0439.545.206
Mechelen · Eq €5,295,570
GRUNENTHAL
BE 0403.085.874
Zaventem · Eq €5,122,762
Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 567 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded20-12-1996
Fiscal year end30-06
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID
0208:0459516615
Also
9925:BE0459516615
Registered
30-12-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.